You are here: Home > Human Cell Lines > Prostate Cell Lines
Prostate Cell Lines 
Asterand offers three pairs of prostate tumor and normal cell lines. Researchers at the Karmanos Cancer Institute, Onyvax Ltd., and Asterand collaborated to derive these cell lines from tumors and adjacent “normal” tissues obtained at the time of prostatectomy. These prostate cell lines were immortalized via replication-defective retrovirus transferring the transforming HPV16 or HPV18 E6 and E7 genes.
All cell lines are provided in cryovial of ~1x106 cells.
 
All of the cell lines available from Asterand were developed in conjunction with different academic institutions.  As a result of our agreements with these institutions, we offer our cell lines to academic and governmental researchers at prices lower than those available to our commercial customers.  If you have any questions about this policy, please email us at advantage@asterand.com.
 
 
 
Sort By:
Page of 1
OPCN-1
Our Price: $6,000.00

OPCN-1:  Derived from normal prostate epithelium from patient with prostate cancer (T1cN0M0; Gleason 3+3). Patient received no chemotherapy, no radiotherapy and no hormone treatment.

OPCN-2
Our Price: $6,000.00

OPCN-2:  Derived from normal prostate epithelium from patient with prostate cancer (PT2aN0M0; Gleason 2+3). Patient received no chemotherapy, radiation or hormone treatment. 

OPCN-3
Our Price: $6,000.00

OPCN-3: Derived from normal prostate epithelium from patient with prostate cancer (T3aN0M0; Gleason 2+2). Patient received no chemotherapy, radiation or hormone treatment.

OPCT-1
Our Price: $6,000.00

OPCT-1: Derived from prostate tumor epithelium (T1cN0M0, Gleason 3+3) Patient received no chemotherapy, no radiotherapy and no hormone treatment.

OPCT-2
Our Price: $6,000.00

OPCT-2: Derived from prostate tumor epithelium (PT2aN0M0; Gleason 2+3). Patient received no chemotherapy, radiation or hormone treatment.

OPCT-3
Our Price: $6,000.00

OPCT-3: Derived from prostate tumor epithelium (T3aN0M0; Gleason 2+2). Patient received no chemotherapy, radiation or hormone treatment.